In meetings of the committee setting limits on healthcare spending for all Connecticut residents, it appears the advocates’ sign on letter and detailed concerns about the Office of Health Strategy’s (OHS’s) Cost Cap project were not heard. The plan is being developed by a Technical Advisory Team, with members chosen only by OHS, including some…

Read More

At Friday’s MAPOC meeting, DSS reported that HUSKY applications were down 40% in May from a year before. This was unexpected given massive increases in unemployment and predictions of over 100,000 new Connecticut Medicaid members because of the pandemic. In January, February and March, applications ran 15% to 20% higher than last year. But a…

Read More

The pandemic has been tragic in both lives lost and economic damage, especially to low wage workers. Our already flawed healthcare system has been seriously disrupted. Insurer profits are up, hospitals are losing money, and Connecticut healthcare jobs in April were down 28,400 from the year before. As the pandemic winds down, the recovery offers…

Read More

With the recent spike in unemployment, many more Connecticut residents will be joining the thousands that were uninsured pre-COVID looking for healthcare coverage. The state has some new options to help. Check AccessHealthCT. You may be surprised to find that you qualify for HUSKY which is comprehensive, free, and includes most Connecticut providers. You may…

Read More

Contrary to earlier concerns, it appears that health insurers are doing pretty well through the COVID pandemic. It appears the costs of treating people with the virus are more than offset by a 60% reduction in other medical care including elective surgeries, routine outpatient care and lower ED visits. The six largest insurers reported $8.6…

Read More

In a nation hungry for good news in fighting the COVID-19 pandemic, remdesivir has emerged as a first ray of hope. The FDA has quickly approved the drug for emergency use with seriously ill patients. However there are concerns that the data supporting remdesivir’s effectiveness has not been published or peer reviewed by independent scientists…

Read More

Not necessarily. COVID-19 could cost the US between $34 billion and $251 billion for testing, treatment and care. Some analysts have predicted that premiums will rise between 4% and 40% next year because of the pandemic. Because consumers, taxpayers and workers ultimately pay the bills, from our taxes, our lost wages, our premiums, and directly…

Read More

Building on previous letters from legal services, the CT Health Policy Project sent a letter today thanking the state for important protections adopted to protect Connecticut’s health during the pandemic. We also urged the state to adopt new policies and expand some already adopted. Require insurers to automatically continue providing commercial insurance during the crisis…

Read More

After the longest economic recovery in US history, we’ve been expecting a recession for a long time. We knew when it came, Connecticut healthcare would be hit hard. But no one expected this. Connecticut didn’t fare well in the last recession and we took longer than other states to build back the jobs we lost.…

Read More

According to State Health Compare’s updated data, 18.1% of Connecticut residents had out-of-pocket health costs that were more than 10% of their family income in 2018. That is up from 17.8% the year before while the burden on the rest of the US went down. While Connecticut’s rate is bad, it’s better than the US…

Read More